000766.SZ
通化金马
SZSE · Healthcare · C 制造业 · CN
CNY 15.68
−1.07%Aug 24, 2026, 09:39 UTC
Tonghua Jinma signed a comprehensive strategic cooperation agreement with Xuanwu Hospital of Capital Medical University to advance clinical research on its Alzheimer's drug and stroke pipeline.
Source:Aug 20, 2026, 07:44 UTC
Tonghua Golden-Horse Pharmaceutical reported H1 2026 revenue of 557 million yuan, down 14.28% year-on-year, and net profit of 7.1046 million yuan, down 57.72% year-on-year.
Source:Aug 6, 2026, 10:47 UTC
Tonghua Jinma's wholly-owned subsidiary Guilin Jinma signed a letter of intent to acquire a controlling stake in Bayajia Pharmaceutical on August 6, 2026.
Source:Jul 14, 2026, 03:32 UTC
China's National Medical Products Administration approved Tonghua Jinma Pharmaceutical Group's new drug Succinic Acid Anweiacridine Tablets (brand name Maoantong) for marketing.